Compounds > imiquimod
Page last updated: 2024-08-24

imiquimod and transforming growth factor beta

imiquimod has been researched along with transforming growth factor beta in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Clark, RA; Edwards, V; Hijnen, D; Huang, SJ; Kim, JE; Kupper, TS; Lambert, J; Miller, DM; Mollet, IG; Murphy, GF; Muthukuru, M; Schanbacher, CF1
Mrowietz, U; Seifert, O1
Calarese, AW; Clark, RA; Hijnen, D; Huang, SJ; Kupper, TS; Miller, DM; Mollet, IG; Murphy, GF; Schanbacher, CF; Schmults, CD1
He, Y; Li, L; Li, W; Li, Y; Liu, D; Pu, D; Wang, Y; Zhang, L1
Marden, G; Stawski, L; Trojanowska, M1
Chen, L; Gao, L; Huang, J; Pang, X; Sun, Y; Wang, H; Wang, J; Wang, T; Zhang, K1
Acinas, O; Alvarez, P; Augustín, JJ; Genre, F; Iglesias, M; Mendiguren, MA; Merino, J; Merino, R; San Segundo, D; Tamayo, E; Vázquez, JA1

Reviews

1 review(s) available for imiquimod and transforming growth factor beta

ArticleYear
Keloid scarring: bench and bedside.
    Archives of dermatological research, 2009, Volume: 301, Issue:4

    Topics: Adult; Aminoquinolines; Cicatrix; Female; Genetic Predisposition to Disease; Humans; Imiquimod; Immunity, Cellular; Interleukin-10; Keloid; Polymorphism, Genetic; Pregnancy; Quality of Life; Signal Transduction; Smad Proteins; Transforming Growth Factor beta

2009

Other Studies

6 other study(ies) available for imiquimod and transforming growth factor beta

ArticleYear
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells.
    The Journal of experimental medicine, 2008, Sep-29, Volume: 205, Issue:10

    Topics: Aminoquinolines; Antigens, CD; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Movement; Down-Regulation; E-Selectin; Endothelial Cells; Forkhead Transcription Factors; Humans; Imiquimod; Immune System; Immunologic Memory; Interleukin-10; Interleukin-6; Lymphocyte Activation; Nitric Oxide Synthase Type II; Skin; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tumor Escape

2008
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.
    The Journal of investigative dermatology, 2009, Volume: 129, Issue:11

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Biopsy; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Division; Granzymes; Humans; Imiquimod; In Vitro Techniques; Interferon-gamma; Interleukin-10; Lymphocyte Activation; Perforin; Pore Forming Cytotoxic Proteins; Signal Transduction; Skin Neoplasms; Transforming Growth Factor beta

2009
The TLR7 agonist Imiquimod promote the immunogenicity of mesenchymal stem cells.
    Biological research, 2015, Jan-17, Volume: 48

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antigens, CD; Cell Differentiation; Cell Proliferation; Flow Cytometry; Gene Expression Regulation; Humans; Imiquimod; Interleukin-12; Interleukin-6; Interleukin-8; L-Lactate Dehydrogenase; Leukocytes, Mononuclear; Membrane Proteins; Mesenchymal Stem Cells; Osteogenesis; Real-Time Polymerase Chain Reaction; Toll-Like Receptor 7; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2015
The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.
    Journal of immunology (Baltimore, Md. : 1950), 2018, 01-01, Volume: 200, Issue:1

    Topics: Adult; Aminoquinolines; Cell Line; Dermis; Endothelium, Vascular; Female; Forkhead Box Protein O3; Humans; Imiquimod; Lipopolysaccharides; Male; Microvessels; Middle Aged; Oligodeoxyribonucleotides; Poly I-C; Proto-Oncogene Protein c-fli-1; RNA, Small Interfering; Scleroderma, Limited; Signal Transduction; Toll-Like Receptors; Transforming Growth Factor beta

2018
Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
    International journal of molecular sciences, 2018, Jun-21, Volume: 19, Issue:7

    Topics: Aminoquinolines; Animals; Cell Proliferation; Dermatologic Agents; Disease Models, Animal; Drugs, Chinese Herbal; Gene Expression Regulation; Humans; Imiquimod; Interleukin-17; Interleukin-18; Interleukin-23; Keratinocytes; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; Psoriasis; Severity of Illness Index; Signal Transduction; Skin; Toll-Like Receptor 8; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2018
Therapeutic Effects of Anti-Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Treatment in Psoriasis and Arthritis.
    Arthritis & rheumatology (Hoboken, N.J.), 2020, Volume: 72, Issue:9

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Arthritis, Experimental; Arthritis, Psoriatic; CD4-Positive T-Lymphocytes; Cell Differentiation; Collagen Type II; Disease Models, Animal; Imiquimod; Interleukin-17; Interleukin-2; Mannans; Membrane Proteins; Mice; Mice, Knockout; Psoriasis; Saccharomyces cerevisiae; Skin; T-Lymphocytes, Regulatory; Th17 Cells; Transforming Growth Factor beta

2020